Skip to main content
SpringerLink
Log in

Familial Pancreatic Cancer

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

The dismal prognosis of ductal pancreatic adenocarcinoma is mainly attributable to advanced tumor stages at the time of diagnosis. Meanwhile, familial pancreatic cancer is an established hereditary tumor entity that is responsible for approximately 3% of pancreatic cancer (PC) cases. Therefore, analysis of the family history may help to identify individuals at increased risk of developing PC. These include members of families with a history of PC as well as those of families with distinct hereditary cancer syndromes such as Peutz-Jeghers syndrome, hereditary pancreatitis, familial atypical multiple mole melanoma syndrome, hereditary breast and ovarian cancer syndrome and hereditary non-polyposis colorectal cancer. In future, the identification of germline mutations in genes predisposing to PC, together with the analysis of exogenous risk factors, could be used for a more precise risk assessment for the development of PC. This may allow the application of invasive screening methods for the identification of early PC or, even better, its precursor lesions in high-risk individuals, providing the option of timely curative pancreatectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cooperman AM. Pancreatic cancer: the bigger picture. Surg Clin North Am 2001; 81: 557–74.

    Article  PubMed  CAS  Google Scholar 

  2. Gold EB, Goldin SB. Epidemiology of and risk factors for pancreatic cancer. Surg Oncol Clin N Am 1998; 7: 67–91.

    PubMed  CAS  Google Scholar 

  3. Kauppinen T, Partanen T, Degerth R, Ojajarvi A. Pancreatic cancer and occupational exposures. Epidemiology 1995; 6: 498–502.

    PubMed  CAS  Google Scholar 

  4. Lowenfels AB, Maisonneuve P, Cavallini G et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433–7.

    Article  PubMed  CAS  Google Scholar 

  5. Silverman DT, Dunn JA, Hoover RN et al. Cigarette smoking and pancreas cancer: A case–control study based on direct interviews. J Natl Cancer Inst 1994; 86: 1510–6.

    PubMed  CAS  Google Scholar 

  6. Boyle P, Maisonneuve P, Bueno dM et al. Cigarette smoking and pancreas cancer: a case-control study of the search programme of the IARC. Int J Cancer 1996; 67: 63–71.

    Article  PubMed  CAS  Google Scholar 

  7. Ehrenthal D, Haeger L, Griffin T, Compton C. Familial pancreatic adenocarcinoma in three generations. A case report and a review of the literature. Cancer 1987; 59: 1661–4.

    Article  PubMed  CAS  Google Scholar 

  8. MacDermott RP, Kramer P. Adenocarcinoma of the pancreas in four siblings. Gastroenterology 1973; 65: 137–9.

    PubMed  CAS  Google Scholar 

  9. Reimer RR, Fraumeni JF, Jr., Ozols RF, Bender R. Pancreatic cancer in father and son. Lancet 1977; 1: 911.

    Article  PubMed  CAS  Google Scholar 

  10. Lynch HT, Lanspa SJ, Fitzgibbons RJ, Jr. et al. Familial pancreatic cancer (Part 1): genetic pathology review. Nebr Med J 1989; 74: 109–12.

    PubMed  CAS  Google Scholar 

  11. Lynch HT, Fitzsimmons ML, Smyrk TC et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 1990; 85: 54–60.

    PubMed  CAS  Google Scholar 

  12. Hruban RH, Petersen GM, Ha PK, Kern SE. Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 1998; 7: 1–23.

    PubMed  CAS  Google Scholar 

  13. Banke MG, Mulvihill JJ, Aston CE. Inheritance of pancreatic cancer in pancreatic cancer-prone families. Med Clin North Am 2000; 84: 677–90.

    Article  PubMed  CAS  Google Scholar 

  14. Applebaum SE, Kant JA, Whitcomb DC, Ellis IH. Genetic testing. Counseling, laboratory, and regulatory issues and the EUROPAC protocol for ethical research in multicenter studies of inherited pancreatic diseases. Med Clin North Am 2000; 84: 575–88.

    Article  PubMed  CAS  Google Scholar 

  15. Bartsch DK, Sina-Frey M, Ziegler A et al. Update of familial pancreatic cancer in Germany. Pancreatology 2001; 1: 510–6.

    Article  PubMed  CAS  Google Scholar 

  16. Falk RT, Pickle LW, Fontham ET et al. Life-style risk factors for pancreatic cancer in Louisiana: a case-control study. Am J Epidemiol 1988; 128: 324–36.

    PubMed  CAS  Google Scholar 

  17. Ghadirian P, Boyle P, Simard A et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol 1991; 10: 183–96.

    PubMed  CAS  Google Scholar 

  18. Fernandez E, La Vecchia C, D'Avanzo B et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. Cancer Epidemiol Biomarkers Prev 1994; 3: 209–12.

    PubMed  CAS  Google Scholar 

  19. Price TF, Payne RL, Oberleitner MG. Familial pancreatic cancer in south Louisiana. Cancer Nurs 1996; 19: 275–82.

    Article  PubMed  CAS  Google Scholar 

  20. Coughlin SS, Calle EE, Patel AV, Thun MJ. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 2000; 11: 915–23.

    Article  PubMed  CAS  Google Scholar 

  21. Schenk M, Schwartz AG, O'Neal E et al. Familial risk of pancreatic cancer. J Natl Cancer Inst 2001; 93: 640–4.

    Article  PubMed  CAS  Google Scholar 

  22. Bartsch DK, Kress R, Sina-Frey M et al. Familial pancreatic cancer in Germany. Int J Cancer (in press).

  23. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer 2003; 103: 525–30.

    Article  PubMed  CAS  Google Scholar 

  24. Tersmette AC, Petersen GM, Offerhaus GJ et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 2001; 7: 738–44.

    PubMed  CAS  Google Scholar 

  25. Jenne DE, Reimann H, Nezu J et al. Peutz–Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18: 38–44.

    Article  PubMed  CAS  Google Scholar 

  26. Su GH, Hruban RH, Bansal RK et al. Germline and somatic mutations of the STK11/LKB1 Peutz–Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999; 154: 1835–40.

    PubMed  CAS  Google Scholar 

  27. Giardiello FM, Welsh SB, Hamilton SR et al. Increased risk of cancer in the Peutz–Jeghers syndrome. N Engl J Med 1987; 316: 1511–4.

    Article  PubMed  CAS  Google Scholar 

  28. Boardman LA, Thibodeau SN, Schaid DJ et al. Increased risk for cancer in patients with the Peutz–Jeghers syndrome. Ann Intern Med 1998; 128: 896–9.

    PubMed  CAS  Google Scholar 

  29. NIH consensus conference. Diagnosis and treatment of early melanoma. JAMA 1992; 268: 1314–9.

    Article  Google Scholar 

  30. Goldstein AM, Fraser MC, Struewing JP et al. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995; 333: 970–4.

    Article  PubMed  CAS  Google Scholar 

  31. Whelan AJ, Bartsch D, Goodfellow PJ. Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene. N Engl J Med 1995; 333: 975–7.

    Article  PubMed  CAS  Google Scholar 

  32. Moskaluk CA, Hruban H, Lietman A et al. Novel germline p16(INK4) allele (Asp145Cys) in a family with multiple pancreatic carcinomas. Mutations in brief no. 148. Hum Mutat 1998; 12: 70.

    Article  PubMed  CAS  Google Scholar 

  33. Borg A, Sandberg T, Nilsson K et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92: 1260–6.

    Article  PubMed  CAS  Google Scholar 

  34. Vasen HFA, Gruis NA, Frants RR et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809–11.

    Article  PubMed  CAS  Google Scholar 

  35. Bartsch DK, Sina-Frey M, Lang S et al. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg 2002; 236: 730–7.

    Article  PubMed  Google Scholar 

  36. Lynch HT, Brand RE, Hogg D et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome. Cancer 2002; 94: 84–96.

    Article  PubMed  CAS  Google Scholar 

  37. Lal G, Liu L, Hogg D et al. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes Chromosomes Cancer 2000; 27: 358–61.

    Article  PubMed  CAS  Google Scholar 

  38. Lynch HT, Brand RE, Lynch JF et al. Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. Gastroenterology 2000; 119: 1756–60.

    PubMed  CAS  Google Scholar 

  39. Lynch HT, Watson P, Conway T et al. Breast cancer family history as a risk factor for early onset breast cancer. Breast Cancer Res Treat 1988; 11: 263–7.

    Article  PubMed  CAS  Google Scholar 

  40. Thompson WD. Genetic epidemiology of breast cancer. Cancer 1994; 74: 279–87.

    Article  PubMed  CAS  Google Scholar 

  41. Eerola H, Blomqvist C, Pukkala E et al. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 2000; 36: 1143–8.

    Article  PubMed  CAS  Google Scholar 

  42. Frank TS, Deffenbaugh AM, Reid JE et al. Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: Analysis of 10,000 individuals. J Clin Oncol 2002; 20: 1480–90.

    Article  PubMed  CAS  Google Scholar 

  43. Tulinius H, Olafsdottir GH, Sigvaldason H et al. Neoplastic diseases in families of breast cancer patients. J Med Genet 1994; 31: 618–21.

    Article  PubMed  CAS  Google Scholar 

  44. Simard J, Tonin P, Durocher F et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat Genet 1994; 8: 392–8.

    Article  PubMed  CAS  Google Scholar 

  45. Thompson D, Easton DF. Cancer Incidence in BRCA1 mutation carriers. J Natl Cancer Inst 2002; 94: 1358–65.

    PubMed  CAS  Google Scholar 

  46. Phelan CM, Lancaster JM, Tonin P et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996; 13: 120–2.

    Article  PubMed  CAS  Google Scholar 

  47. Lal G, Liu G, Schmocker B et al. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 2000; 60: 409–16.

    PubMed  CAS  Google Scholar 

  48. Tonin P, Weber B, Offit K et al. Frequency of recurrent BRCA1 and BRCA2 mutations in ashkenazi jewish breast cancer families. Nature Med 1996; 2: 1179–83.

    Article  PubMed  CAS  Google Scholar 

  49. Ozcelik H, Schmocker B, Di Nicola N et al. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients [Letter]. Nat Genet 1997; 16: 17–8.

    Article  PubMed  CAS  Google Scholar 

  50. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 1999; 91: 1310–6.

    Google Scholar 

  51. Goggins M, Schutte M, Lu J et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996; 56: 5360–4.

    PubMed  CAS  Google Scholar 

  52. Figer A, Irmin L, Geva R et al. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. Br J Cancer 2001; 84: 478–81.

    Article  PubMed  CAS  Google Scholar 

  53. Murphy KM, Brune KA, Griffin C et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 2002; 62: 3789–93.

    PubMed  CAS  Google Scholar 

  54. Hahn SA, Greenhalf B, Ellis I et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 2003; 95: 214–21.

    Article  PubMed  CAS  Google Scholar 

  55. Lynch HT, Brand RE, Deters CA et al. Hereditary pancreatic cancer. Pancreatology 2001; 1: 466–71.

    Article  PubMed  CAS  Google Scholar 

  56. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215–25.

    Article  PubMed  CAS  Google Scholar 

  57. Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75: 1027–38.

    Article  PubMed  CAS  Google Scholar 

  58. Peltomäki P, Gao X, Mecklin J-P. Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations. Familial Cancer 2001; 1: 9–15.

    Article  PubMed  Google Scholar 

  59. Lynch HT, Voorhees GJ, Lanspa SJ et al. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 1985; 52: 271–3.

    PubMed  CAS  Google Scholar 

  60. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141–5.

    Article  PubMed  CAS  Google Scholar 

  61. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682–707.

    Article  PubMed  CAS  Google Scholar 

  62. Chen JM, Mercier B, Audrezet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000; 37: 67–9.

    Article  PubMed  CAS  Google Scholar 

  63. Pfutzer RH, Barmada MM, Brunskill AP et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000; 119: 615–23.

    Article  PubMed  CAS  Google Scholar 

  64. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25: 213–6.

    Article  PubMed  CAS  Google Scholar 

  65. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group. Med Clin North Am 2000; 84: 565–73.

    Article  PubMed  CAS  Google Scholar 

  66. Rieder H, Sina-Frey M, Ziegler A et al. German national case collection of familial pancreatic cancer – clinical-genetic analysis of the first 21 families. Onkologie 2002; 25: 262–6.

    Article  PubMed  CAS  Google Scholar 

  67. Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: surveillance and treatment strategies for affected families. Pancreatology 2001; 1: 477–85.

    Article  PubMed  CAS  Google Scholar 

  68. Rulyak SJ, Lowenfels AB, Maisonneuve P, Brentnall TA. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 2003; 124: 1292–9.

    Article  PubMed  Google Scholar 

  69. Eberle MA, Pfutzer R, Pogue-Geile KL et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 2002; 70: 1044–8.

    Article  PubMed  CAS  Google Scholar 

  70. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res 2003; 63: 2585–8.

    PubMed  CAS  Google Scholar 

  71. Brentnall TA. Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 2000; 84: 707–18.

    Article  PubMed  CAS  Google Scholar 

  72. Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology 2001; 1: 416–22.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Clinical Genetics, Marburg, Germany

    Harald Rieder

  2. Department of Surgery, Philipps-University, 35041, Marburg, Germany; Tel:

    Detlef K. Bartsch

Authors
  1. Harald Rieder
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Detlef K. Bartsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rieder, H., Bartsch, D.K. Familial Pancreatic Cancer. Familial Cancer 3, 69–74 (2004). https://doi.org/10.1023/B:FAME.0000026822.67291.a1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:FAME.0000026822.67291.a1

Search

Navigation